The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Cancer stem cell surface markers on normal stem cells
Open accessAbstract
The cancer stem cell (CSC) hypothesis has captured the attention of many scientists. It is believed that elimination of CSCs could possibly eradicate the whole cancer. CSC surface markers provide molecular targeted therapies for various cancers, using therapeutic antibodies specific for the CSC surface markers. Various CSC surface markers have been identified and published. Interestingly, most of the markers used to identify CSCs are derived from surface markers present on human embryonic stem cells (hESCs) or adult stem cells. In this review, we classify the currently known 40 CSC surface markers into 3 different categories, in terms of their expression in hESCs, adult stem cells, and normal tissue cells. Approximately 73% of current CSC surface markers appear to be present on embryonic or adult stem cells, and they are rarely expressed on normal tissue cells. The remaining CSC surface markers are considerably expressed even in normal tissue cells, and some of them have been extensively validated as CSC surface markers by various research groups. We discuss the significance of the categorized CSC surface markers, and provide insight into why surface markers on hESCs are an attractive source to find novel surface markers on CSCs. [BMB Reports 2017; 50(6): 285-298].
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Identification of stem cells in small intestine and colon by marker gene Lgr5
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., et al. (2007) · Nature · doi:10.1038/nature06196 · Cited by 5,687
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2018 · Cited by 2,820
Ben-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,523
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,999
Direct isolation of human central nervous system stem cells
Uchida, N., Buck, D. W., He, D., Reitsma, M. J., Masek, M., Phan, T. V., Tsukamoto, A. S., Gage, F. H., & Weissman, I. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14720 · Cited by 1,849
AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells
Yin, A. H., Miraglia, S., Zanjani, E. D., Almeida-Porada, G., Ogawa, M., Leary, A. G., Olweus, J., Kearney, J., & Buck, D. W. (1997) · Blood · doi:10.1182/blood.v90.12.5002 · Cited by 1,822
Identification of cells initiating human melanomas
Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., et al. (2008) · Nature · doi:10.1038/nature06489 · Cited by 1,415
A tumorigenic subpopulation with stem cell properties in melanomas
Fang, D., Nguyen, T. K., Leishear, K., Finko, R., Kulp, A. N., Hotz, S., Van Belle, P. A., Xu, X., Elder, D. E., & Herlyn, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1343 · Cited by 1,280
Civin, C. I., Strauss, L. C., Brovall, C., Fackler, M. J., Schwartz, J. F., & Shaper, J. H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.1.157 · Cited by 1,202
Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.038 · Cited by 1,192
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,149
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Zöller, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3023 · Cited by 1,112
Characterization of a human B lymphocyte-specific antigen.
Stashenko, P., Nadler, L. M., Hardy, R., & Schlossman, S. F. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1678 · Cited by 1,076
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative
Initiative, T. I. S. C. (2007) · Nature Biotechnology · doi:10.1038/nbt1318 · Cited by 1,073
Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
Takaishi, S., Okumura, T., Tu, S., Wang, S. S. W., Shibata, W., Vigneshwaran, R., Gordon, S. A. K., Shimada, Y., & Wang, T. C. (2009) · Stem Cells · doi:10.1002/stem.30 · Cited by 1,039
How do stem cells find their way home?
Lapidot, T., Dar, A., & Kollet, O. (2005) · Blood · doi:10.1182/blood-2005-04-1417 · Cited by 985
Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells
Ho, M. M., Ng, A. V., Lam, S., & Hung, J. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3557 · Cited by 947
Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment
Notta, F., Doulatov, S., Laurenti, E., Poeppl, A., Jurisica, I., & Dick, J. E. (2011) · Science · doi:10.1126/science.1201219 · Cited by 919
Stem Cells and Cancer: Two Faces of Eve
Clarke, M. F., & Fuller, M. (2006) · Cell · doi:10.1016/j.cell.2006.03.011 · Cited by 905
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Zhou, B.-B. S., Zhang, H., Damelin, M., Geles, K. G., Grindley, J. C., & Dirks, P. B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2137 · Cited by 841
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
Smith, M. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206939 · Cited by 835
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
Lee, A. S., Tang, C., Rao, M. S., Weissman, I. L., & Wu, J. C. (2013) · Nature Medicine · doi:10.1038/nm.3267 · Cited by 727
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
Boiko, A. D., Razorenova, O. V., van de Rijn, M., Swetter, S. M., Johnson, D. L., Ly, D. P., Butler, P. D., Yang, G. P., Joshua, B., Kaplan, M. J., et al. (2010) · Nature · doi:10.1038/nature09161 · Cited by 720
Imayoshi, I., Sakamoto, M., Yamaguchi, M., Mori, K., & Kageyama, R. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4987-09.2010 · Cited by 716
Galy, A., Travis, M., Cen, D., & Chen, B. (1995) · Immunity · doi:10.1016/1074-7613(95)90175-2 · Cited by 693
Kim, J., Woo, A. J., Chu, J., Snow, J. W., Fujiwara, Y., Kim, C. G., Cantor, A. B., & Orkin, S. H. (2010) · Cell · doi:10.1016/j.cell.2010.09.010 · Cited by 669
Tetraspanins: push and pull in suppressing and promoting metastasis
Zöller, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2543 · Cited by 663
Zhang, W. C., Shyh-Chang, N., Yang, H., Rai, A., Umashankar, S., Ma, S., Soh, B. S., Sun, L. L., Tai, B. C., Nga, M. E., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.050 · Cited by 660
Integrin Alpha 6 Regulates Glioblastoma Stem Cells
Lathia, J. D., Gallagher, J., Heddleston, J. M., Wang, J., Eyler, C. E., MacSwords, J., Wu, Q., Vasanji, A., McLendon, R. E., Hjelmeland, A. B., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.02.018 · Cited by 660
Sutherland, H. J., Lansdorp, P. M., Henkelman, D. H., Eaves, A. C., & Eaves, C. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3584 · Cited by 648
CD13 is a therapeutic target in human liver cancer stem cells
Haraguchi, N., Ishii, H., Mimori, K., Tanaka, F., Ohkuma, M., Kim, H. M., Akita, H., Takiuchi, D., Hatano, H., Nagano, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42550 · Cited by 605
Quintana, E., Shackleton, M., Foster, H. R., Fullen, D. R., Sabel, M. S., Johnson, T. M., & Morrison, S. J. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.012 · Cited by 599
Miettinen, M., & Lasota, J. (2005) · Applied Immunohistochemistry & Molecular Morphology · doi:10.1097/01.pai.0000173054.83414.22 · Cited by 556
Zannettino, A. C. W., Paton, S., Arthur, A., Khor, F., Itescu, S., Gimble, J. M., & Gronthos, S. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21210 · Cited by 553
A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
Pang, R., Law, W. L., Chu, A. C. Y., Poon, J. T., Lam, C. S. C., Chow, A. K. M., Ng, L., Cheung, L. W. H., Lan, X. R., Lan, H. Y., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.001 · Cited by 540
Unique multipotent cells in adult human mesenchymal cell populations
Kuroda, Y., Kitada, M., Wakao, S., Nishikawa, K., Tanimura, Y., Makinoshima, H., Goda, M., Akashi, H., Inutsuka, A., Niwa, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911647107 · Cited by 525
Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
Jaggupilli, A., & Elkord, E. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/708036 · Cited by 510
SSEA-4 identifies mesenchymal stem cells from bone marrow
Gang, E. J., Bosnakovski, D., Figueiredo, C. A., Visser, J. W., & Perlingeiro, R. C. R. (2007) · Blood · doi:10.1182/blood-2005-11-010504 · Cited by 509
Balancing natural killer cell activation through paired receptors
Martinet, L., & Smyth, M. J. (2015) · Nature Reviews Immunology · doi:10.1038/nri3799 · Cited by 485
TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
Kikushige, Y., Shima, T., Takayanagi, S.-I., Urata, S., Miyamoto, T., Iwasaki, H., Takenaka, K., Teshima, T., Tanaka, T., Inagaki, Y., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.014 · Cited by 477
Novel Markers for the Prospective Isolation of Human MSC
BÜHRING, H., BATTULA, V. L., TREML, S., SCHEWE, B., KANZ, L., & VOGEL, W. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1392.000 · Cited by 454
CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
Curley, M. D., Therrien, V. A., Cummings, C. L., Sergent, P. A., Koulouris, C. R., Friel, A. M., Roberts, D. J., Seiden, M. V., Scadden, D. T., Rueda, B. R., et al. (2009) · Stem Cells · doi:10.1002/stem.236 · Cited by 440
Epithelial cell adhesion molecule expression (CD326) in cancer: A short review
Patriarca, C., Macchi, R. M., Marschner, A. K., & Mellstedt, H. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.04.002 · Cited by 434
Dll1- and Dll4-Mediated Notch Signaling Are Required for Homeostasis of Intestinal Stem Cells
Pellegrinet, L., Rodilla, V., Liu, Z., Chen, S., Koch, U., Espinosa, L., Kaestner, K. H., Kopan, R., Lewis, J., & Radtke, F. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.005 · Cited by 431
DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Hoey, T., Yen, W.-C., Axelrod, F., Basi, J., Donigian, L., Dylla, S., Fitch-Bruhns, M., Lazetic, S., Park, I.-K., Sato, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.019 · Cited by 398
Tirino, V., Desiderio, V., Paino, F., De Rosa, A., Papaccio, F., La Noce, M., Laino, L., De Francesco, F., & Papaccio, G. (2013) · The FASEB Journal · doi:10.1096/fj.12-218222 · Cited by 395
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
Hosen, N., Park, C. Y., Tatsumi, N., Oji, Y., Sugiyama, H., Gramatzki, M., Krensky, A. M., & Weissman, I. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704271104 · Cited by 379
The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation
Kemper, K., Sprick, M. R., de Bree, M., Scopelliti, A., Vermeulen, L., Hoek, M., Zeilstra, J., Pals, S. T., Mehmet, H., Stassi, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1820 · Cited by 372
Ringe, J., Strassburg, S., Neumann, K., Endres, M., Notter, M., Burmester, G., Kaps, C., & Sittinger, M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21172 · Cited by 371
CD13/APN is activated by angiogenic signals and is essential for capillary tube formation
Bhagwat, S. V., Lahdenranta, J., Giordano, R., Arap, W., Pasqualini, R., & Shapiro, L. H. (2001) · Blood · doi:10.1182/blood.v97.3.652 · Cited by 334
Tumour Biological Aspects of CD24, A Mucin-Like Adhesion Molecule
Kristiansen, G., Sammar, M., & Altevogt, P. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032357.16261.c5 · Cited by 316
The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
Thapa, R., & Wilson, G. D. (2016) · Stem Cells International · doi:10.1155/2016/2087204 · Cited by 312
Grosse‐Gehling, P., Fargeas, C. A., Dittfeld, C., Garbe, Y., Alison, M. R., Corbeil, D., & Kunz‐Schughart, L. A. (2013) · The Journal of Pathology · doi:10.1002/path.4086 · Cited by 301
Properties of four human embryonic stem cell lines maintained in a feeder‐free culture system
Carpenter, M. K., Rosler, E. S., Fisk, G. J., Brandenberger, R., Ares, X., Miura, T., Lucero, M., & Rao, M. S. (2004) · Developmental Dynamics · doi:10.1002/dvdy.10431 · Cited by 287
Comparison of Mesenchymal Stem Cell Markers in Multiple Human Adult Stem Cells
Maleki, M., Ghanbarvand, F., Behvarz, M. R., Ejtemaei, M., & Ghadirkhomi, E. (2014) · International Journal of Stem Cells · doi:10.15283/ijsc.2014.7.2.118 · Cited by 284
Redox regulation in stem-like cancer cells by CD44 variant isoforms
Nagano, O., Okazaki, S., & Saya, H. (2013) · Oncogene · doi:10.1038/onc.2012.638 · Cited by 280
ABCB5 is a limbal stem cell gene required for corneal development and repair
Ksander, B. R., Kolovou, P. E., Wilson, B. J., Saab, K. R., Guo, Q., Ma, J., McGuire, S. P., Gregory, M. S., Vincent, W. J. B., Perez, V. L., et al. (2014) · Nature · doi:10.1038/nature13426 · Cited by 279
Närvä, E., Autio, R., Rahkonen, N., Kong, L., Harrison, N., Kitsberg, D., Borghese, L., Itskovitz-Eldor, J., Rasool, O., Dvorak, P., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1615 · Cited by 277
Schober, M., & Fuchs, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107807108 · Cited by 261
Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling
Rajasekhar, V. K., Studer, L., Gerald, W., Socci, N. D., & Scher, H. I. (2011) · Nature Communications · doi:10.1038/ncomms1159 · Cited by 259
Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells
Kemper, K., Prasetyanti, P. R., De Lau, W., Rodermond, H., Clevers, H., & Medema, J. P. (2012) · Stem Cells · doi:10.1002/stem.1233 · Cited by 257
On the Stem Cell Origin of Cancer
Sell, S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091064 · Cited by 257
Medof, M. E., Lublin, D. M., Holers, V. M., Ayers, D. J., Getty, R. R., Leykam, J. F., Atkinson, J. P., & Tykocinski, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2007 · Cited by 254
Yen, W.-C., Fischer, M. M., Axelrod, F., Bond, C., Cain, J., Cancilla, B., Henner, W. R., Meisner, R., Sato, A., Shah, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2808 · Cited by 246
Choo, A. B., Tan, H. L., Ang, S. N., Fong, W. J., Chin, A., Lo, J., Zheng, L., Hentze, H., Philp, R. J., Oh, S. K. W., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0576 · Cited by 243
The Role of chemokine receptor CXCR4 in breast cancer metastasis.
Mukherjee, D., & Zhao, J. (2013) · Europe PMC (PubMed Central) · Cited by 235
EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma
Terris, B., Cavard, C., & Perret, C. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.026 · Cited by 233
Zhao, W., Ji, X., Zhang, F., Li, L., & Ma, L. (2012) · Molecules · doi:10.3390/molecules17066196 · Cited by 224
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
Herrmann, H., Sadovnik, I., Cerny-Reiterer, S., Rülicke, T., Stefanzl, G., Willmann, M., Hoermann, G., Bilban, M., Blatt, K., Herndlhofer, S., et al. (2014) · Blood · doi:10.1182/blood-2013-10-536078 · Cited by 223 · cited 1×
“CD26 (DPP-4) Dipeptidyl peptidase iv, FDA-approved target Yes Hematopoietic Rare (intestine, kidney, male, female tissues, activated T, B, NK cells) Colorectal, leukemia (73-75)”
BackgroundWang, F., Scoville, D., He, X. C., Mahe, M. M., Box, A., Perry, J. M., Smith, N. R., Lei, N. Y., Davies, P. S., Fuller, M. K., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.050 · Cited by 219
Singh, J. K., Farnie, G., Bundred, N. J., Simões, B. M., Shergill, A., Landberg, G., Howell, S. J., & Clarke, R. B. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1063 · Cited by 217
Identification of CD44+CD24+ gastric cancer stem cells
Zhang, C., Li, C., He, F., Cai, Y., & Yang, H. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1038-5 · Cited by 216
Miyauchi, J., Kelleher, C., Yang, Y., Wong, G., Clark, S., Minden, M., Minkin, S., & McCulloch, E. (1987) · Blood · doi:10.1182/blood.v70.3.657.657 · Cited by 208
CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
Lau, W. M., Teng, E., Chong, H. S., Lopez, K. A. P., Tay, A. Y. L., Salto-Tellez, M., Shabbir, A., So, J. B. Y., & Chan, S. L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2309 · Cited by 206
Chen, T., Yang, K., Yu, J., Meng, W., Yuan, D., Bi, F., Liu, F., Liu, J., Dai, B., Chen, X., et al. (2012) · Cell Research · doi:10.1038/cr.2011.109 · Cited by 193
Yoshikawa, M., Tsuchihashi, K., Ishimoto, T., Yae, T., Motohara, T., Sugihara, E., Onishi, N., Masuko, T., Yoshizawa, K., Kawashiri, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3609-t · Cited by 191
Kaiser, J. (2015) · Science · doi:10.1126/science.347.6219.226 · Cited by 191
Levin, T. G., Powell, A. E., Davies, P. S., Silk, A. D., Dismuke, A. D., Anderson, E. C., Swain, J. R., & Wong, M. H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.053 · Cited by 191
He, J., Liu, Y., Zhu, T. S., Zhu, J., DiMeco, F., Vescovi, A. L., Heth, J., Muraszko, K. M., Fan, X., & Lubman, D. M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010744 · Cited by 174
CD49f Enhances Multipotency and Maintains Stemness Through the Direct Regulation of OCT4 and SOX2
Yu, K., Yang, S., Jung, J., Kim, S., Ko, K., Han, D., Park, S., Choi, S. W., Kang, S., Schöler, H. R., et al. (2012) · Stem Cells · doi:10.1002/stem.1052 · Cited by 171
Chen, L., Fan, J., Chen, H., Meng, Z., Chen, Z., Wang, P., & Liu, L. (2014) · Scientific Reports · doi:10.1038/srep05911 · Cited by 169
Chang, W.-W., Lee, C. H., Lee, P., Lin, J., Hsu, C.-W., Hung, J.-T., Lin, J.-J., Yu, J.-C., Shao, L.-E., Yu, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804979105 · Cited by 169
LGR5 positivity defines stem-like cells in colorectal cancer
Hirsch, D., Barker, N., McNeil, N., Hu, Y., Camps, J., McKinnon, K., Clevers, H., Ried, T., & Gaiser, T. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt377 · Cited by 168
Lgr proteins in epithelial stem cell biology
Barker, N., Tan, S., & Clevers, H. C. (2013) · Development · doi:10.1242/dev.083113 · Cited by 160
Schopperle, W. M., & DeWolf, W. C. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0597 · Cited by 157
Salcido, C. D., Larochelle, A., Taylor, B. J., Dunbar, C. E., & Varticovski, L. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605668 · Cited by 153
Ou, X., O’Leary, H. A., & Broxmeyer, H. E. (2013) · Blood · doi:10.1182/blood-2013-02-487470 · Cited by 146
Islam, F., Gopalan, V., Smith, R. A., & Lam, A. K.-Y. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.018 · Cited by 145
Wilson, S., WILKINSON, G. F., & Milligan, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413475200 · Cited by 144
Wang, P. L., O'Farrell, S., Clayberger, C., & Krensky, A. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.8.2600 · Cited by 139
CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
Hirata, K., Suzuki, H., Imaeda, H., Matsuzaki, J., Tsugawa, H., Nagano, O., Asakura, K., Saya, H., & Hibi∥, T. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.314 · Cited by 139
Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus
Bach, P., Abel, T., Hoffmann, C. M., Gal, Z., Braun, G., Voelker, I., Ball, C. R., Johnston, I., Lauer, U. M., Herold‐Mende, C. C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2221 · Cited by 130
Mice carrying a CD20 gene disruption
O’Keefe, T. L., Williams, G. T., Davies, S. L., & Neuberger, M. S. (1998) · Immunogenetics · doi:10.1007/s002510050412 · Cited by 129
Fischer, M. M., Yen, W.-C., Kapoun, A. M., Wang, M., O’Young, G., Lewicki, J. A., Gurney, A. L., & Hoey, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2817 · Cited by 124
Role of Cripto-1 in Stem Cell Maintenance and Malignant Progression
Bianco, C., Rangel, M. C., de Castro, N. P., Nagaoka, T., Rollman, K., Gonzales, M., & Salomon, D. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100102 · Cited by 124
CD133, Selectively Targeting the Root of Cancer
Schmohl, J., & Vallera, D. A. (2016) · Toxins · doi:10.3390/toxins8060165 · Cited by 124
CD133: to be or not to be, is this the real question?
Irollo, E., & Pirozzi, G. (2013) · Europe PMC (PubMed Central) · Cited by 122
Dubrovska, A., Hartung, A., Bouchez, L. C., Walker, J. R., Reddy, V. A., Cho, C. Y., & Schultz, P. G. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.105 · Cited by 119
Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15
Mao, X., Zhang, X., Xue, X., Guo, G., Wang, P., Zhang, W., Fei, Z., Zhen, H., You, S., & Yang, H. (2009) · Translational Oncology · doi:10.1593/tlo.09136 · Cited by 113
Sundberg, M., Jansson, L., Ketolainen, J. M., PIHLAJAMÄKI, H. K., Suuronen, R., Skottman, H., Inzunza, J., Hovatta, O., & Narkilahti, S. (2008) · Stem Cell Research · doi:10.1016/j.scr.2008.08.001 · Cited by 112
Corominas-Faja, B., Cufí, S., Oliveras‐Ferraros, C., Cuyàs, E., López‐Bonet, E., Lupu, R., Alarcón, T., Vellón, L., Iglesias, J. M., Leis, O., et al. (2013) · Cell Cycle · doi:10.4161/cc.26173 · Cited by 110
Fibroblast growth factor signaling in embryonic and cancer stem cells
Dvořák, P., Dvořáková, D., & Hampl, A. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.095 · Cited by 103
Ng, V. Y., Ang, S. N., Chan, J. X., & Choo, A. B. H. (2009) · Stem Cells · doi:10.1002/stem.221 · Cited by 100
Dennis, J. E., Esterly, K., Awadallah, A., Parrish, C. R., Poynter, G. M., & Goltry, K. L. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0204 · Cited by 98
Li, Y., Zeng, H., Xu, R., Liu, B., & Li, Z. (2009) · Stem Cells · doi:10.1002/stem.234 · Cited by 88
Human Intestinal Tissue with Adult Stem Cell Properties Derived from Pluripotent Stem Cells
Forster, R. E., Chiba, K., Schaeffer, L., Regalado, S. G., Lai, C. S., Gao, Q., Kiani, S., Farin, H. F., Clevers, H. C., Cost, G. J., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.05.001 · Cited by 88
Apáti, Á., Orbán, T. I., Varga, N., Nemeth, A. H., Schamberger, A., Krízsik, V., Erdélyi‐Belle, B., Homolya, L., Várady, G., Padányi, R., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.010 · Cited by 88
Cell-Cell Signaling Through NOTCH Regulates Human Embryonic Stem Cell Proliferation
Fox, V., Gokhale, P. J., Walsh, J. R., Matin, M. M., Jones, M., & Andrews, P. W. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0368 · Cited by 79
Vassilopoulos, A., Chisholm, C. L., Lahusen, T. J., Zheng, H., & Deng, C.-X. (2013) · Oncogene · doi:10.1038/onc.2013.516 · Cited by 78
Chen, J., Wang, J., Chen, D., Yang, J., Yang, C., Zhang, Y., Zhang, H., & Dou, J. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-7 · Cited by 69
Hsu, D. M., Agarwal, S., Benham, A. L., Coarfa, C., Trahan, D. N., Chen, Z., Stowers, P. N., Courtney, A. N., Lakoma, A., Barbieri, E., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4056 · Cited by 68
Prognostic Significance of CD55 Expression in Breast Cancer
Ikeda, J., Morii, E., Liu, Y., Qiu, Y., Nakamichi, N., Jokoji, R., Miyoshi, Y., Noguchi, S., & Aozasa, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1844 · Cited by 63
Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia
Yamazaki, H., Xu, C. W., Naito, M., Nishida, H., Okamoto, T., Ghani, F. I., Iwata, S., Inukai, T., Sugita, K., & Morimoto, C. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.098 · Cited by 61
Saroufim, A., Messai, Y., Hasmim, M., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.71 · Cited by 60
Amaral, A. T., Manara, M. C., Berghuis, D., Ordóñez, J. L., Biscuola, M., López‐García, M. Á., Osuna, D., Lucarelli, E., Alviano, F., Lankester, A. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085814 · Cited by 53
Dong, W., Du, J., Shen, H., Gao, D., Li, Z., Wang, G., Mu, X., & Liu, Q. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0899-9 · Cited by 48
Li, M., Chang, C., Lathia, J. D., Wang, L., Pacenta, H. L., Cotleur, A. C., & Ransohoff, R. M. (2010) · Glia · doi:10.1002/glia.21080 · Cited by 45
Kim, Y. J., Yu, J. M., Joo, H. J., Kim, H. K., Cho, H. H., Bae, Y. C., & Jung, J. S. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0285-4 · Cited by 45
CD13 promotes mesenchymal stem cell-mediated regeneration of ischemic muscle
Rahman, M., Subramani, J., Ghosh, M., Denninger, J. K., Takeda, K., Fong, G., Carlson, M. E., & Shapiro, L. H. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2013.00402 · Cited by 44
A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma
Waldron, N. N., Barsky, S. H., Dougherty, P. R., & Vallera, D. A. (2013) · Targeted Oncology · doi:10.1007/s11523-013-0290-9 · Cited by 44
Kim, W., Choi, H. S., Lee, H. M., Jang, Y., & Ryu, C. J. (2014) · Stem Cells · doi:10.1002/stem.1765 · Cited by 40
Self-citationThe role of the granulocyte colony-stimulating factor receptor (G-CSF-R) in disease
Alister, C. W. (2006) · Frontiers in bioscience · doi:10.2741/2086 · Cited by 39
CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family
Zage, P. E., Whittle, S. B., & Shohet, J. M. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25656 · Cited by 34
Choi, H. S., Kim, H., Won, A., Kim, J.-J., Son, C., Kim, K. S., Ko, J. H., Lee, M.-Y., Kim, C., & Ryu, C. J. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0632-6 · Cited by 31
Self-citationIdentification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas
Buishand, F. O., Arkesteijn, G. J. A., Feenstra, L. R., Oorsprong, C. W. D., Mestemaker, M., Starke, A. A. R., Speel, E. M., Kirpensteijn, J., & Mol, J. A. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0032 · Cited by 29
Choi, H. S., Kim, W.-T., Kim, H., Kim, J.-J., Ko, J., Lee, S.-W., Jang, Y. J., Kim, S. J., Lee, M.-J., Jung, H.-S., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0265 · Cited by 23
Self-citationWei, Q., Tang, Y. J., Voisin, V., Sato, S., Hirata, M., Whetstone, H., Han, I., Ailles, L., Bader, G. D., Wunder, J. S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5375 · Cited by 23
Garg, S., Madkaikar, M. R., & Ghosh, K. (2013) · International Journal of Stem Cells · doi:10.15283/ijsc.2013.6.2.129 · Cited by 20
Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia
Sadras, T., Perugini, M., Kok, C. H., Iarossi, D. G., Heatley, S. L., Brumatti, G., Samuel, M. S., To, L. B., Lewis, I. D., Lopez, A. F., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ab1013-559r · Cited by 20
Lost in Translation: Regulation of ABCG2 Expression in Human Embryonic Stem Cells
Padmanabhan, R. (2014) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000180 · Cited by 7
Cited by
Cancer stem cells—Origins and biomarkers: Perspectives for targeted personalized therapies
Walcher, L., Kistenmacher, A.-K., Suo, H., Kitte, R., Dluczek, S., Strauß, A., Blaudszun, A.-R., Yevsa, T., Fricke, S., & Kossatz-Boehlert, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01280 · Cited by 1,007
Stem cell programs in cancer initiation, progression, and therapy resistance
Huang, T., Song, X., Xu, D., Tiek, D., Goenka, A., Wu, B., Sastry, N., Hu, B., & Cheng, S.-Y. (2020) · Theranostics · doi:10.7150/thno.41648 · Cited by 524
The role of CD133 in cancer: a concise review
Glumac, P. M., & LeBeau, A. M. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0198-1 · Cited by 400
Therapy resistance mediated by cancer stem cells
Steinbichler, T. B., Dudás, J., Skvortsov, S., Ganswindt, U., Riechelmann, H., & Skvortsova, I.-I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.006 · Cited by 286
Advances in adoptive cellular therapy for colorectal cancer: A narrative review
Yi, X., & Hu, W. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-6196 · Cited by 14
Metadata
- Authors
- Kim, W.-T., & Ryu, C. J.
- Venue
- BMB Reports
- Published
- 2017-06-30
- Volume
- 50
- Issue
- 6
- Pages
- 285-298
- ISSN
- 1976-6696 (ISSN-L)
- 1976-670X
- OpenAlex
- W2595717913
- Cited by
- 332
- References
- 141
- FWCI
- 10.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.